Navigation Links
Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
Date:1/16/2009

New Vice President Will lead Business Development and Communications for Company's International Line of Business

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Abt Associates announced that Valerie DeFillipo, a reproductive health and rights expert, has joined the company as Vice President for Business Development and Communications for its International Line of Business. DeFillipo joins Abt Associates from the International Planned Parenthood Federation (IPPF) in London, where for the last five years she served as Director of External Affairs.

"Valerie will play a significant role in helping us grow and diversify our international development portfolio," said Abt Associates Group Vice President for International Development, Tessie San Martin. "Her experience working with a variety of international donor governments and multi-lateral agencies, as well as her expertise in policy advocacy, communications and resource mobilization strengthens our business development capability. We are delighted to have her on our team."

While at IPPF DeFillipo was a lead organizer of the Countdown 2015 Global Roundtable; a founding board member of the Safe Abortion Action Fund, a global platform funded by multiple European donor governments to reduce maternal mortality in developing countries; and led IPPF's global rebranding effort.

Prior to joining IPPF, DeFillipo enjoyed a broad and varied career with Planned Parenthood Federation of America (PPFA). While there she directed the Miami and Florida Keys affiliate, founded the international public policy arm of PPFA, and led international business development, managing family planning clinics and providing training and technical assistance support to family planning programs in the Balkans, Middle East, Asia and the Caribbean.

An accomplished presenter and media spokesperson, DeFillipo has wide experience in strategic positioning, issue advocacy and communications campaigns as well as practical experience working with a range of donor governments, multi-lateral agencies and parliamentary groups on policy formulation and resource mobilization.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
2. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
3. Malaysian Healthcare Industry Is in Good Shape
4. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
5. 2009 is Healthy for Asia
6. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
7. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
9. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
10. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
11. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2017)...  Trianni, Inc. („TRIANNI") gab heute bekannt, man ... über die Verwendung der The Trianni Mouse unterschrieben, ... Entdeckung monoklonaler Antikörper. Die Trianni Plattform ... das Janssen den Zugang zu einer ... für die schelle Isolierung vollständig menschlicher Therapeutika optimiert ...
(Date:2/15/2017)... 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), ... fourth quarter and full year ended December 31, ... for Vanda as we continued to demonstrate strong ... exclusivity for Fanapt," said Mihael H. Polymeropoulos, M.D., ... pipeline with important 2017 milestones underscores Vanda,s commitment ...
(Date:2/15/2017)... Feb. 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, will ... presentation) at 8:00 AM EST on Thursday, February 16, ... clinical program, the recently announced closing of a $10.5 ... To participate in the live call and ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health ... Diameter Health technology in the hands of Lantana analysts. The high-performance platform of ... and public health entities – all those mining value from clinical data – ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):